View all studies | RSV Treatment

RSV Treatment Research Study

Consider taking part in our latest research study for people who have developed cold or flu-like symptoms in the past 3-5 days. This study is assessing the safety and effectiveness of an investigational medication in people with Respiratory Syncytial Virus (RSV) infection who are at risk of progression to severe illness. People aged 65 years or older who have not tested positive for Covid since symptom onset may be eligible, other criteria apply. Financial compensation will also be provided for time and travel expenses.

Submit to learn more:


When you register your interest with Accellacare, our clinical research specialists will review your information at no cost and connect you with studies you may be eligible for. When we find a match, Accellacare may contact you for further pre-screening or we may share your information with a local site office for them to contact you directly. Your data will be processed as outlined in the Accellacare Privacy Notice.


Data Protection

As the data controller for accellacare.us, Accellacare is committed to protecting the information that you provide. Where you give us your consent, we may use your information to: (a) identify appropriate clinical trials for you and to let you know about them; and/or (b) send you invitations to participate in future study opportunities. You can withdraw your consent at any time, but we may continue some limited processing where we have other legal grounds for doing so.

Please enter the security code: